M. OʼReilly
The University of Texas MD Anderson Cancer Center · 59 works · 7,352 citations · h-index 14
Top works
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
- Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
- Inhibition of Angiogenesis In Vivo by Interleukin 12
- Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
- Vascular Endothelial Growth Factor/Vascular Permeability Factor is Temporally and Spatially Correlated with Ocular Angiogenesis In a Primate Model
- Angiostatin: A Circulating Endothelial Cell Inhibitor That Suppresses Angiogenesis and Tumor Growth
- Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases.
- Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
- Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy
- The radiation abscopal anti-tumor effect is mediated through p53
- Radiation Combined With Antiangiogenic and Antivascular Agents
- Phase I trial of bevacizumab (BV) with concurrent radiotherapy (RT) and capecitabine (CAP) in locally advanced pancreatic adenocarcinoma (PA)
- Angiostatin: An endogenous inhibitor of angiogenesis and of tumor growth
- IMRT reduces lung irradiation in distal esophageal cancer over 3D CRT
- Phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small cell lung cancer.
- AZD2171, an oral, highly potent VEGFR signaling inhibitor, in combination with gefitinib or paclitaxel: Results of a study in an orthotopic human lung adenocarcinoma model.
- RhuMab VEGF (bevacizumab) with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer: An active, well tolerated regimen
- OC-0143: A Bayesian randomisation trial of IMRT vs. PSPT for locally advanced non-small cell lung carcinoma
- Targeted therapy against VEGFR and EGFR signaling with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic mouse model of human non-small cell lung cancer
- Concurrent Chemotherapy and Proton Beam Therapy for Esophageal Cancer